NICE draft guidance recommends rivaroxaban (Xarelto) to prevent blood clots in people who have had a heart attack
Broad Bi-Specific Antibody Collaboration Now Includes Targets that Could Lead to New Cancer Immunotherapies
WACO, Texas, Oct.
- Third-Quarter Adjusted EPS Above Previous Guidance Range, Including Results From Discontinued Operations Related to Mylan Transaction -
ABBOTT PARK, Ill.,
LONDON, October 22, 2014 /PRNewswire/ --
U.S. Food and Drug Administration accepts filing of new drug application for empagliflozin/metformin fixed-dose combination
RIDGEFIELD, Conn. and INDIANAPOLIS, Oct. 21, 2014 /PRNewswire/ -- The U.S.
THOUSAND OAKS, Calif., Oct.
FDA Advisory Committee Recommends Approval of KALYDECO® (ivacaftor) for Use in People with Cystic Fibrosis Ages 6 and Older Who Have the R117H Mutation
Acquisition Updates, Drug Approval, Drug Development Discontinuation, and Contract Update - Research Reports on AbbVie, Gilead, Pfizer, Lilly and Aetna
Editor Note: For more information about this release, please scroll to bottom.
NEW YORK, October 20, 2014